Emergency Ventilator Splitting Between Two or More Patients (COVID-19)
- Conditions
- COVID-19
- Interventions
- Device: Emergency Ventilator Splitter
- Registration Number
- NCT04381013
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this study is to develop a safe, easily scalable, and simple method to split a single ventilator for use amongst two or more patients, thus serving as a capacity bridge to save patient lives until manufacturers can produce enough ventilators.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
-
Phase I
- Undergoing routine thoracic surgery which will include the use of a dual lumen endotracheal tube at Stanford.
-
Phase II
- Able to give consent
- On venovenous extracorporeal membrane oxygenation for reason other than COVID-19
-
Phase III
- Able to give consent
- Infected with COVID-19 and will likely require mechanical ventilation.
-
Phase I
- Significant cardiac comorbidities
- Liver disease
-
Phase II
- Significant cardiac comorbidities
- Pre or Post-transplant patient
- Infection with COVID-19
-
Phase III
- Co-infection with disease aside from COVID-19
- Severely ill requiring high ventilator requirements and not stable for ventilator splitting
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Phase 2: ECHO treatment Emergency Ventilator Splitter During care with Extracorporeal Membrane Oxygenation (ECMO) for non-SARS-CoV-2, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 24 hours. Phase 1: Routine surgery Emergency Ventilator Splitter As part of routine cardio-thoracic surgery, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 1 minute. Phase 3: COVID-19 treatment Emergency Ventilator Splitter Endotracheal tubes split from ventilator delivering oxygen independently to two patients with COVID-19 disease for up to 1 hour.
- Primary Outcome Measures
Name Time Method Completion of 24-hour test Up to 1 hour This outcome will measure whether the device will function for respiratory support for 1 hour (yes or no; phase 3 only)
Completion of 1-minute test Up to 1 minute This outcome will measure whether the device will function for respiratory support for 1 minute (yes or no; phase 1 only)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University
πΊπΈStanford, California, United States